Retinitis pigmentosa Trials in Miami, United States
Conditions / Retinitis pigmentosa / Miami, United States
Retinitis pigmentosa is a medical condition with active clinical research programs worldwide.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06388200 | A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05589714 | Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants | RECRUITING | — |
| NCT05537220 | Oral N-acetylcysteine for Retinitis Pigmentosa | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05203939 | Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT05158296 | Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) | TERMINATED | PHASE2/PHASE3 |
| NCT01860092 | New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System | TERMINATED | — |
| NCT00447980 | A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa | COMPLETED | PHASE2 |
| NCT01233609 | Trial of Oral Valproic Acid for Retinitis Pigmentosa | COMPLETED | PHASE2 |
| NCT05748873 | Promising ROd-cone DYstrophy Gene therapY | RECRUITING | PHASE1/PHASE2 |
| NCT04127006 | Rate of Progression in EYS Related Retinal Degeneration | ACTIVE_NOT_RECRUITING | — |